[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07676136":3,"trial-entities:NCT07676136":92,"trial-summary:NCT07676136":97},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":6,"overall_status":7,"completion_date":8,"status_verified_date":9,"last_update_date":10,"start_date":11,"sponsor_name":12,"lead_sponsor_class":13,"has_dmc":14,"brief_summary":15,"detailed_description":16,"conditions":17,"keywords":23,"study_type":25,"primary_purpose":26,"phases":27,"enrollment_info":29,"interventions":32,"primary_outcomes":44,"secondary_outcomes":56,"sex":57,"minimum_age":58,"maximum_age":16,"healthy_volunteers":14,"eligibility_criteria":59,"std_ages":73,"locations":76,"central_contacts":85,"overall_officials":86,"references":90,"see_also_links":91},"NCT07676136","83851","A Pilot Study Using Gut-Directed Hypnotherapy for Hospitalized Patients","NOT_YET_RECRUITING","2028-07","2026-06","2026-06-30","2026-07","Stanford University","OTHER",false,"The purpose of the study is to compare the effectiveness of recorded gut-directed hypnosis to an educational recording in people with chronic problems in their gastrointestinal (GI) system. Patients who are hospitalized at Stanford Hospital for worsening pain and\u002For nausea will be considered for enrollment.",null,[18,19,20,21,22],"Disorders of Gut-brain Interaction","Inflammatory Bowel Disease (IBD)","Irritable Bowel Syndrome","Abdominal Pain","Esophageal Disease",[24],"hypnosis","INTERVENTIONAL","TREATMENT",[28],"NA",{"count":30,"type":31},26,"ESTIMATED",[33,39],{"type":34,"name":35,"description":36,"armGroupLabels":37},"BEHAVIORAL","Gut directed hypnotherapy via telephone intervention","Participants will undergo a self-directed gut-directed hypnosis intervention over the telephone.",[38],"Hypnosis",{"type":34,"name":40,"description":41,"armGroupLabels":42},"Educational recording","Participants will listen to educational material over the telephone about their gastrointestinal symptoms.",[43],"Education",[45,49,53],{"measure":46,"description":47,"timeFrame":48},"Recruitment rate","Recruitment rate is the proportion enrolled among eligible patients approached.","Up to 1 year.",{"measure":50,"description":51,"timeFrame":52},"Number of participants who adhered to intervention","Proportion of participants completing ≥1 hypnosis session during hospitalization and total number of listens","3 months.",{"measure":54,"description":55,"timeFrame":52},"Retention rate","Retention rate is defined as survey completion at baseline, 1 week, 1 month, and 3 months.",[],"ALL","18 Years",{"inclusion":60,"exclusion":64,"raw_text":72},[61,62,63],"Adults admitted to the GI inpatient service with expected length of stay \\>24 hours","Prior diagnosis of a disorder of gut-brain interaction, esophageal disorder, or inflammatory bowel disease","Reason for hospitalization related to symptom management for exacerbation of visceral pain and\u002For nausea.",[65,66,67,68,69,70,71],"Currently using hypnosis","severe developmental delay or cognitive impairment","serious mental illness (i.e. psychosis or dissociation)","hearing impairment","Non-English speaking","enrolled in another trial for GI symptom management","admitted for GI procedure","Inclusion Criteria:\n\n* Adults admitted to the GI inpatient service with expected length of stay \\>24 hours\n* Prior diagnosis of a disorder of gut-brain interaction, esophageal disorder, or inflammatory bowel disease\n* Reason for hospitalization related to symptom management for exacerbation of visceral pain and\u002For nausea.\n\nExclusion Criteria:\n\n* Currently using hypnosis\n* severe developmental delay or cognitive impairment\n* serious mental illness (i.e. psychosis or dissociation)\n* hearing impairment\n* Non-English speaking\n* enrolled in another trial for GI symptom management\n* admitted for GI procedure",[74,75],"ADULT","OLDER_ADULT",[77],{"facility":12,"city":78,"state":79,"zip":80,"country":81,"geoPoint":82},"Stanford","California","94305","United States",{"lat":83,"lon":84},37.42411,-122.16608,[],[87],{"name":88,"affiliation":12,"role":89},"Irene Sonu, MD","PRINCIPAL_INVESTIGATOR",[],[],{"nct_id":4,"conditions":93,"biomarkers":96},[18,94,95,20],"Esophageal Disorder","Inflammatory Bowel Disease",[],{"nct_id":4,"found":98,"summary":99,"prompt_version":109},true,{"design":100,"status":101,"heading":102,"summary":103,"follow_up":104,"word_count":105,"commitments":106,"compensation":107,"drugs_mentioned":108},"This is an interventional study comparing two behavioral approaches. It plans to enroll 26 participants.","completed","Pilot Study: Gut-Directed Hypnotherapy for Hospitalized Patients","This study is looking at whether gut-directed hypnotherapy can help hospitalized patients with chronic gastrointestinal (GI) problems like Irritable Bowel Syndrome (IBS) or Inflammatory Bowel Disease (IBD). You might be able to join if you are an adult admitted to Stanford Hospital for worsening pain or nausea related to these conditions. The study will compare self-directed gut-directed hypnotherapy given over the phone to an educational recording about GI symptoms. Researchers want to see how many people join, stick with the intervention, and stay in the study. The study aims to enroll 26 participants and its current status is unclear.","Researchers will measure adherence and retention for up to 3 months, and recruitment for up to 1 year.",99,"Participants will undergo a self-directed gut-directed hypnosis intervention or listen to an educational recording over the telephone.","Not stated in the trial record.",[40],"v2"]